RE:RE:RE:RE:RE:Re test of last years lows?The SP has been declining prior to the financing despite the HIV NASH(which is bigger market than HIV MDR) despite the preclinical sort1 news, despite new experience CEO, despite the announcement of the general NASH. Despite the good PR.
I guess the only thing they have learned is so far they haven't learned from past failed marketing efforts.
jeffm34 wrote: It doesn't help when you ignore the bigger more important firms to do a sweetheart deal (at the time) with your friends you still have at NB. There were rumours when they did their prior financing that they pissed off the wrong people back then too. I guess they don't learn. I'm curious to see the next short report. I think someone is sending a clear message to management